Home/Filings/4/0001486189-25-000013
4//SEC Filing

Chang Michael L. 4

Accession 0001486189-25-000013

CIK 0001479681other

Filed

Apr 13, 8:00 PM ET

Accepted

Apr 14, 3:35 PM ET

Size

9.7 KB

Accession

0001486189-25-000013

Insider Transaction Report

Form 4
Period: 2025-03-01
Chang Michael L.
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-03-01+1,25081,307 total(indirect: See note (3))
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-10+2,5005,000 total
    Exercise: $0.00From: 2026-03-01Exp: 2028-03-01Common Stock (2,500 underlying)
  • Tax Payment

    Common Stock

    2025-04-04$72.10/sh266$19,17881,041 total(indirect: See note (3))
Footnotes (4)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]Of the 1,250 shares issued subsequent to vesting, 266 shares were sold to cover tax withholding obligations.
  • [F3]Michael Chang PLLC ("CHANG") is the direct beneficial owner of 80,057 shares of Common Stock. Dr. Chang as the 100% owner and sole manager of CHANG, is an indirect beneficial owner of such shares. Dr. Chang is the direct owner of 984 shares.
  • [F4]On March 10, 2025, the Reporting Person was granted 2,500 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.

Issuer

Nutex Health, Inc.

CIK 0001479681

Entity typeother

Related Parties

1
  • filerCIK 0001919832

Filing Metadata

Form type
4
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 3:35 PM ET
Size
9.7 KB